Iridex Corp balance sheet
At the end of fiscal 2025, Iridex Corp had total assets of $29.2m, total liabilities of $24.2m and shareholders' equity of $4.9m. It held $6.0m in cash against $3.7m of debt: net cash of $2.3m.
Balance sheet
| Fiscal year | 2009Jan 2010 | 2010Jan 2011 | 2011Dec 2011 | 2012Dec 2012 | 2013Dec 2013 | 2014Jan 2015 | 2015Jan 2016 | 2016Dec 2016 | 2017Dec 2017 | 2018Dec 2018 | 2019Dec 2019 | 2020Jan 2021 | 2021Jan 2022 | 2022Dec 2022 | 2023Dec 2023 | 2024Dec 2024 | 2025Jan 2026 | LTMJul 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash and equivalents | 8 | 8 | 11 | 12 | 13 | 13 | 10 | 24 | 22 | 21 | 13 | 12 | 24 | 14 | 7 | 2 | 6 | 5 |
| Receivables | — | 5 | 6 | 5 | 7 | 8 | 9 | 10 | 8 | 9 | 9 | 7 | 7 | 6 | 7 | 6 | 8 | 6 |
| Inventory | — | 6 | 7 | 8 | 11 | 9 | 11 | 12 | 9 | 9 | 8 | 6 | 8 | 11 | 10 | 11 | 8 | 10 |
| Total current assets | — | 26 | 30 | 27 | 32 | 33 | 31 | 46 | 39 | 40 | 31 | 25 | 42 | 36 | 27 | 24 | 25 | 24 |
| Goodwill | — | 0 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 |
| Total assets | — | 29 | 32 | 29 | 34 | 42 | 42 | 48 | 42 | 42 | 35 | 28 | 49 | 42 | 34 | 29 | 29 | 27 |
| Accounts payable | — | 2 | 2 | 2 | 2 | 2 | 2 | 2 | 2 | 3 | 3 | 1 | 3 | 4 | 4 | 7 | 5 | 7 |
| Deferred revenue (current) | — | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 3 | 2 | 1 | 1 | 2 | 2 | 2 | 2 | 2 | 2 |
| Total current liabilities | — | 9 | 9 | 6 | 7 | 7 | 7 | 8 | 10 | 11 | 10 | 9 | 13 | 12 | 13 | 17 | 13 | 13 |
| Short-term debt | — | — | — | — | — | — | — | — | — | — | — | 1 | — | — | — | 2 | — | — |
| Long-term debt | — | — | — | — | — | — | — | — | — | — | — | 1 | — | — | 0 | 1 | 4 | 4 |
| Total debt | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | — | 0 | 0 | 4 | 4 | 4 |
| Total liabilities | — | 10 | 10 | 7 | 8 | 8 | 8 | 9 | 11 | 12 | 12 | 11 | 25 | 25 | 25 | 27 | 24 | 24 |
| Shareholders' equity | 15 | 19 | 22 | 22 | 26 | 34 | 34 | 39 | 31 | 30 | 23 | 17 | 23 | 17 | 10 | 2 | 5 | 4 |
| Net debt (negative = net cash) | −8 | −8 | −11 | −12 | −13 | −13 | −10 | −24 | −22 | −21 | −13 | −10 | −24 | −14 | −7 | 2 | −2 | −1 |
| Shares outstanding | — | 9m | 9m | 8m | 10m | 10m | 10m | 11m | 12m | 14m | 14m | 14m | 16m | 16m | 16m | 17m | 17m | 17m |
| Quarter | 2024 Q3Sept 2024 | 2024 Q4Dec 2024 | 2025 Q1Mar 2025 | 2025 Q2Jun 2025 | 2025 Q3Sept 2025 | 2025 Q4Jan 2026 | 2026 Q1Apr 2026 | 2026 Q2Jul 2026 |
|---|---|---|---|---|---|---|---|---|
| Receivables | 6 | 6 | 7 | 7 | 7 | 8 | 7 | 6 |
| Inventory | 11 | 11 | 10 | 8 | 7 | 8 | 9 | 10 |
| Total current assets | 24 | 24 | 29 | 27 | 24 | 25 | 25 | 24 |
| Goodwill | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 |
| Total assets | 30 | 29 | 34 | 32 | 28 | 29 | 28 | 27 |
| Accounts payable | 6 | 7 | 6 | 5 | 4 | 5 | 6 | 7 |
| Deferred revenue (current) | 2 | 2 | 2 | 2 | 2 | 2 | 2 | 2 |
| Total current liabilities | 16 | 17 | 15 | 14 | 12 | 13 | 13 | 13 |
| Short-term debt | 1 | 2 | — | — | — | — | — | — |
| Long-term debt | 1 | 1 | 4 | 4 | 4 | 4 | 4 | 4 |
| Total debt | 3 | 3 | 4 | 4 | 4 | 4 | 4 | 4 |
| Total liabilities | 28 | 27 | 27 | 26 | 24 | 24 | 24 | 24 |
| Shareholders' equity | 3 | 2 | 1 | 6 | 5 | 5 | 5 | 4 |
| Non-controlling interests and other (assets − liabilities − equity) | — | — | 6 | — | — | — | — | — |
| Shares outstanding | 17m | 17m | 17m | 17m | 17m | 17m | 17m | 17m |
Compare with peers
- Senseonics Holdings, Inc. balance sheet
- Apyx Medical Corp balance sheet
- Clearpoint Neuro, Inc. balance sheet
- Koru Medical Systems, Inc. balance sheet
- Trisalus Life Sciences, Inc. balance sheet
Head to head: IRIX vs SENSAPYX vs IRIXCLPT vs IRIX
More: Health Care Equipment stocks compared, Health Care sector, rankings of US companies